An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model

Kidney International

Volumn 91, Issue 5, 2017, Pages 1115-1125

  Kobayashi, Ryu ^a   Wakui, Hiromichi ^a   Azushima, Kengo ^a   Uneda, Kazushi ^a   Haku, Sona ^a   Ohki, Kohji ^a   Haruhara, Kotaro ^a   Kinguchi, Sho ^a   Matsuda, Miyuki ^a   Ohsawa, Masato ^a   Toya, Yoshiyuki ^a   Nishiyama, Akira ^b   Yamashita, Akio ^a   Tanabe, Katsuyuki ^c   Maeshima, Yohei ^c   Umemura, Satoshi ^a   Tamura, Kouichi ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

chronic kidney disease; hypertension; renal tubules; renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II TYPE 1 RECEPTOR ASSOCIATED PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; AGTR1A PROTEIN, MOUSE; AGTRAP PROTEIN, MOUSE; EPITHELIAL SODIUM CHANNEL; RENIN; SCNN1A PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; HYPERTENSION; LIMIT OF QUANTITATION; MALE; MOUSE; NEPHRECTOMY; NONHUMAN; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SYSTOLIC BLOOD PRESSURE; ANIMAL; BLOOD; BLOOD PRESSURE; C57BL MOUSE; COMPLICATION; GENETICS; HUMAN; KIDNEY; KNOCKOUT MOUSE; METABOLISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BLOOD PRESSURE; DOWN-REGULATION; EPITHELIAL SODIUM CHANNELS; HUMANS; HYPERTENSION; KIDNEY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, ANGIOTENSIN, TYPE 1; RENAL INSUFFICIENCY, CHRONIC; RENIN; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85009274788     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2016.10.035     Document Type: Article

References (40)

1. 1 Townsend, R.R., Taler, S.J., Management of hypertension in chronic kidney disease. Nat Rev Nephrol 11 (2015), 555–563.
2. 2 Olowu, W.A., Pre-treatment considerations in childhood hypertension due to chronic kidney disease. World J Nephrol 4 (2015), 500–510.
3. 3 Campese, V.M., Mitra, N., Sandee, D., Hypertension in renal parenchymal disease: why is it so resistant to treatment?. Kidney Int 69 (2006), 967–973.
4. 4 Klein, I.H., Ligtenberg, G., Neumann, J., et al. Sympathetic nerve activity is inappropriately increased in chronic renal disease. J Am Soc Nephrol 14 (2003), 3239–3244.
5. 5 Kobori, H., Nangaku, M., Navar, L.G., et al. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59 (2007), 251–287.
6. 6 Daviet, L., Lehtonen, J.Y., Tamura, K., et al. Cloning and characterization of ATRAP, a novel protein that interacts with the angiotensin II type 1 receptor. J Biol Chem 274 (1999), 17058–17062.
7. 7 Lopez-Ilasaca, M., Liu, X., Tamura, K., et al. The angiotensin II type I receptor-associated protein, ATRAP, is a transmembrane protein and a modulator of angiotensin II signaling. Mol Biol Cell 14 (2003), 5038–5050.
8. 8 Tamura, K., Wakui, H., Maeda, A., et al. The physiology and pathophysiology of a novel angiotensin receptor-binding protein ATRAP/Agtrap. Curr Pharm Des 19 (2013), 3043–3048.
9. 9 Azuma, K., Tamura, K., Shigenaga, A., et al. Novel regulatory effect of angiotensin II type 1 receptor-interacting molecule on vascular smooth muscle cells. Hypertension 50 (2007), 926–932.
10. 10 Wakui, H., Tamura, K., Tanaka, Y., et al. Cardiac-specific activation of angiotensin II type 1 receptor-associated protein completely suppresses cardiac hypertrophy in chronic angiotensin II-infused mice. Hypertension 55 (2010), 1157–1164.
11. 11 Wakui, H., Dejima, T., Tamura, K., et al. Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertension. Cardiovasc Res 100 (2013), 511–519.
12. 12 Wakui, H., Uneda, K., Tamura, K., et al. Renal tubule angiotensin II type 1 receptor-associated protein promotes natriuresis and inhibits salt-sensitive blood pressure elevation. J Am Heart Assoc, 19, 2015, e001594.
13. 13 Tsurumi, Y., Tamura, K., Tanaka, Y., et al. Interacting molecule of AT1 receptor, ATRAP, is colocalized with AT1 receptor in the mouse renal tubules. Kidney Int 69 (2006), 488–494.
14. 14 Masuda, S., Tamura, K., Wakui, H., et al. Expression of angiotensin II type 1 receptor-interacting molecule in normal human kidney and IgA nephropathy. Am J Physiol Renal Physiol 299 (2010), F720–F731.
15. 15 Ohsawa, M., Tamura, K., Wakui, H., et al. Deletion of the angiotensin II type 1 receptor-associated protein enhances renal sodium reabsorption and exacerbates angiotensin II-mediated hypertension. Kidney Int 86 (2014), 570–581.
16. 16 Wakui, H., Tamura, K., Masuda, S., et al. Enhanced angiotensin receptor-associated protein in renal tubule suppresses angiotensin-dependent hypertension. Hypertension 61 (2013), 1203–1210.
17. 17 Ma, L.J., Fogo, A.B., Model of robust induction of glomerulosclerosis in mice: importance of genetic background. Kidney Int 64 (2003), 350–355.
18. 18 Leelahavanichkul, A., Yan, Q., Hu, X., et al. Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model. Kidney Int 78 (2010), 1136–1153.
19. 19 Ogawa, M., Suzuki, J., Takayama, K., et al. Impaired post-infarction cardiac remodeling in chronic kidney disease is due to excessive renin release. Lab Invest 92 (2012), 1766–1776.
20. 20 Crowley, S.D., The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension. Antioxid Redox Signal 20 (2014), 102–120.
21. 21 Wenzel, U., Turner, J.E., Krebs, C., et al. Immune mechanisms in arterial hypertension. J Am Soc Nephrol 27 (2016), 677–686.
22. 22 Baylis, C., Nitric oxide synthase derangements and hypertension in kidney disease. Curr Opin Nephrol Hypertens 21 (2012), 1–6.
23. 23 Richter, C.M., Role of endothelin in chronic renal failure–developments in renal involvement. Rheumatology (Oxford) 45 Suppl 3 (2006), iii36–iii38.
24. 24 Taylor, E.N., Curhan, G.C., Forman, J.P., Parathyroid hormone and the risk of incident hypertension. J Hypertens 26 (2008), 1390–1394.
25. 25 Jiang, B., Morimoto, S., Yang, J., et al. Parathyroid hormone-related protein upregulates interleukin-1beta-induced nitric oxide synthesis. Hypertension 30 (1997), 922–927.
26. 26 Wakui, H., Tamura, K., Matsuda, M., et al. Intrarenal suppression of angiotensin II type 1 receptor binding molecule in angiotensin II-infused mice. Am J Physiol Renal Physiol 299 (2010), F991–F1003.
27. 27 Zaika, O., Mamenko, M., Staruschenko, A., et al. Direct activation of ENaC by angiotensin II: recent advances and new insights. Curr Hypertens Rep 15 (2013), 17–24.
28. 28 Peti-Peterdi, J., Warnock, D.G., Bell, P.D., Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors. J Am Soc Nephrol 13 (2002), 1131–1135.
29. 29 Mamenko, M., Zaika, O., Prieto, M.C., et al. Chronic angiotensin II infusion drives extensive aldosterone-independent epithelial Na+ channel activation. Hypertension 62 (2013), 1111–1122.
30. 30 Mamenko, M., Zaika, O., Ilatovskaya, D.V., et al. Angiotensin II increases activity of the epithelial Na+ channel (ENaC) in distal nephron additively to aldosterone. J Biol Chem 287 (2012), 660–671.
31. 31 Christensen, B.M., Perrier, R., Wang, Q., et al. Sodium and potassium balance depends on αENaC expression in connecting tubule. J Am Soc Nephrol 21 (2010), 1942–1951.
32. 32 Sriramula, S., Francis, J., Tumor necrosis factor - alpha is essential for angiotensin ii-induced ventricular remodeling: role for oxidative stress. PLoS One, 10, 2015, e0138372.
33. 33 DiPetrillo, K., Coutermarsh, B., Soucy, N., et al. Tumor necrosis factor induces sodium retention in diabetic rats through sequential effects on distal tubule cells. Kidney Int 65 (2014), 1676–1683.
34. 34 Czikora, I., Alli, A., Bao, H.F., et al. A novel tumor necrosis factor-mediated mechanism of direct epithelial sodium channel activation. Am J Respir Crit Care Med 190 (2014), 522–532.
35. 35 Tanabe, K., Lanaspa, M.A., Kitagawa, W., et al. Nicorandil as a novel therapy for advanced diabetic nephropathy in the eNOS-deficient mouse. Am J Physiol Renal Physiol 302 (2012), F1151–F1160.
36. 36 Guzik, T.J., Hoch, N.E., Brown, K.A., et al. Role of T cell in the genesis of angiotensin II-induced hypertension and vascular dysfunction. J Exp Med 204 (2007), 2449–2460.
37. 37 Shigenaga, A., Tamura, K., Wakui, H., et al. Effect of olmesartan on tissue expression balance between angiotensin II receptor and its inhibitory binding molecule. Hypertension 52 (2008), 672–678.
38. 38 Bivona, B.J., Park, S., Harrison-Bernard, L.M., Glomerular filtration rate determinations in conscious type II diabetic mice. Am J Physiol Renal Physiol 300 (2011), F618–F625.
39. 39 Zhang, H., Zhang, A., Kohan, D.E., et al. Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention. Proc Natl Acad Sci U S A 102 (2005), 9406–9411.
40. 40 Yang, S.S., Morimoto, T., Rai, T., et al. Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model. Cell Metab 5 (2007), 331–344.